Rotator Cuff Tear Repair Clinical Trial
— RAPIDREHABOfficial title:
Prospective, Randomized Clinical Trial Comparing Early Versus Delayed Postoperative Mobilization After Arthroscopic Rotator Cuff Tear Reapair.
Arthroscopic suture for complete and partial >50% thickness Rotator Cuff Tears (RCT) is the
gold standard. However, there is no evidence of superiority of delayed postoperative
mobilization protocols versus early ones, in terms of ROM, pain, quality of life and
complications in last review published in 2019 by AAOS. Although, excessive immobilization
can lead into stiffness, neuropathic pain or adhesive capsulitis. All of these are
complications which can diminish patient quality of life or prolong their return to work or
sports activities.
This is an experimental, prospective, non-blind, comparative, randomized clinical trial,
between two options of treatment. On one treatment branch, we will continue applying our
standard postoperative 4 weeks immobilization rehabilitation program with a sling in
adduction and internal rotation. On the other treatment branch, we will start passive
mobilization during second week after surgery, including controlled external rotation
movements. All recruited patients will be followed-up during 12 months.
Our main objective is to compare differences in terms of functionality (using ASES scale).
Secondary objectives are to compare differences in terms of ROM, functionality (using CMS and
UCLA scales), pain (using VAS score), need of analgesic drugs, quality of life (using EQ-5D
scale), return to previous work and sports activities, patient adhesion to protocol,
complications and MRI rotator cuff retear ratio at 12 months follow-up.
After this study, we hope to develop a new postoperative mobilization protocol for patients.
This protocol will be focused on timing, and self-administrated exercises in order to involve
patients in their recovery, in the fastest and safest way for them.
Status | Not yet recruiting |
Enrollment | 64 |
Est. completion date | December 31, 2023 |
Est. primary completion date | September 30, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Age: Less tan 70 years old. - Sex: Male or Female. - Treatment: Arthroscopic RCT suture. - RCT type: Degenerative, total or partial >50% thickness, less than 3 cm length tear. - MRI Tear Classification: Patté's in coronal view I or II, Goutalier's <2, Fukuda's <2 and Seebauer´s 1A maximum. Exclusion Criteria: - Not meet the inclusion criteria. - Previous surgical procedure in affected shoulder. - Have been treated with 2 or more glucocorticoid injections in last year. - High anesthetic risk. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Borja Alcobía-Díaz MD, PhD |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Functionality | Functionality assessment using ASES scale | 12 months after surgery | |
Secondary | Functionality-Constant-Murley scale | Functionality assessment using Constant-Murley scale | 12 months after surgery | |
Secondary | Functionality-UCLA | Functionality assessment using UCLA scale | 12 months after surgery | |
Secondary | Pain | Pain estimation according to visual analogic scale | 12 months after surgery | |
Secondary | Range of motion | Range of motion measured in degrees of a circle | 12 months after surgery | |
Secondary | Analgesic use | Need of analgesic drugs during the follow up period | 12 months after surgery | |
Secondary | Quality of life | Quality of life according to EQ-5D scale | 12 months after surgery | |
Secondary | Complications | Complications related to the surgery or rehabilitation | 12 months after surgery | |
Secondary | MRI rotator cuff retear ratio | MRI rotator cuff retear ratio determinate by MRI | 12 months after surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05584553 -
PMCF Study on the Safety, Performance and Clinical Benefits Data of the ToggleLoc™ 2.9mm and JuggerLoc™ in the Shoulder
|